Press
releases

16th January – SYNTHELIS, the French expert in cell-free biomanufacturing technology, announced the signature on 25 November 2023 of an agreement to acquire the company from Vincent Poher, a Grenoble-based entrepreneur specializing in in-vitro diagnostics. Synthelis has thus become SYNTHELIS BIOTECH since that date.

9th March – SYNTHELIS and A5 SCIENCE have signed a strategic partnership to offer their clients a joint offering of custom production followed by validation of the protein folding and conformation using atomic force microscopy imaging. 

12th April – SYNTHELIS and PEACCEL have signed a strategic partnership to offer their clients a one-stop shop combinant Artificial Intelligence (AI) and Cell-Free lead expression for accelerated drug discovery.